Literature DB >> 8380078

Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system.

Z Yao1, W Jackson, B Forghani, C Grose.   

Abstract

The unique short region of the varicella-zoster virus (VZV) genome contains two open reading frames which encode glycoproteins designated gpI and gpIV (herpes simplex virus homologs gE and gI, respectively). Like its herpesviral counterpart gE, the VZV gpI gene product functions as a cell surface receptor (V. Litwin, W. Jackson, and C. Grose, J. Virol. 66:3643-3651, 1992). To evaluate the biosynthesis of the two VZV glycoproteins and further explore their relationship to one another, the two glycoprotein genes were individually cloned into a pTM1 vector under control of the T7 promoter. Transfection of the cloned gpI or gpIV construct into HeLa cells previously infected with vaccinia recombinant virus expressing bacteriophage T7 polymerase resulted in a much higher level expression of each VZV glycoprotein than previously achieved. Synthesis of both gpI and gpIV included intermediary partially glycosylated forms and mature N- and O-linked final product. Transfections in the presence of 32Pi demonstrated that the mature forms of both gpI and gpIV were phosphorylated, while similar experiments with [35S]sulfate showed that only the mature gpI was sulfated. When gpI and gpIV were coexpressed in the same cell, the two glycoproteins were complexed to each other, as both proteins could be immunoprecipitated by antibodies against either gpI or gpIV. Coprecipitation did not occur as a result of a shared epitope, because gpI expressed alone was not precipitated by antibody to gpIV, and gpIV expressed alone was not precipitated by antibody to gpI. Pulse-chase analysis demonstrated that the gpI-gpIV association occurred early in processing; furthermore, this complex formation interfered with posttranslational modifications and thereby reduced the M(r)s of the mature forms of both gpI and gpIV. Similarly, the molecular masses of the cotransfected gene products corresponded with those of the infected cell glycoproteins, a result which suggested that authentic gpI and gpIV were ordinarily found within a complex. Thus, the adjacent open reading frames 67 and 68 code for two glycoproteins which in turn form a distinctive sulfated and phosphorylated cell surface complex with receptor properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380078      PMCID: PMC237364     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction.

Authors:  Z Yao; D H Jones; C Grose
Journal:  PCR Methods Appl       Date:  1992-02

2.  CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.

Authors:  B Crise; L Buonocore; J K Rose
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Genetic basis of the neurovirulence of pseudorabies virus.

Authors:  B Lomniczi; S Watanabe; T Ben-Porat; A S Kaplan
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

4.  Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.

Authors:  E A Montalvo; R T Parmley; C Grose
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Presence of markers for virulence in the unique short region or repeat region or both of pseudorabies hybrid viruses.

Authors:  A Berns; A van den Ouweland; W Quint; J van Oirschot; A Gielkens
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain.

Authors:  A S Shaw; K E Amrein; C Hammond; D F Stern; B M Sefton; J K Rose
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

7.  Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1.

Authors:  S Bell; M Cranage; L Borysiewicz; T Minson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor.

Authors:  V Litwin; M Sandor; C Grose
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

9.  Sulphated glycoproteins induced by herpes simplex virus.

Authors:  R G Hope; J Palfreyman; M Suh; H S Marsden
Journal:  J Gen Virol       Date:  1982-02       Impact factor: 3.891

10.  Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens.

Authors:  T Okuno; K Yamanishi; K Shiraki; M Takahashi
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

View more
  39 in total

1.  Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain.

Authors:  Z H Wang; M D Gershon; O Lungu; Z Zhu; A A Gershon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions.

Authors:  T N McMillan; D C Johnson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  The gE and gI homologs from two alphaherpesviruses have conserved and divergent neuroinvasive properties.

Authors:  A C Knapp; P J Husak; L W Enquist
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread.

Authors:  Wendy J Collins; David C Johnson
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection.

Authors:  Barbara Berarducci; Minako Ikoma; Shaye Stamatis; Marvin Sommer; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.

Authors:  S Mallory; M Sommer; A M Arvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Structure-function analysis of the gE-gI complex of feline herpesvirus: mapping of gI domains required for gE-gI interaction, intracellular transport, and cell-to-cell spread.

Authors:  J D Mijnes; B C Lutters; A C Vlot; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network.

Authors:  A Alconada; U Bauer; B Hoflack
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

9.  Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Authors:  Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

10.  Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex).

Authors:  Z Yao; C Grose
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.